RADIESSE INJECTABLE IMPLANT (DERMAL FILLERS)
FDA premarket approval P050052/S091 · decided 2017-04-26
Approval details
- PMA number
- P050052
- Supplement
- S091
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol - OSB
- Trade name
- RADIESSE INJECTABLE IMPLANT (DERMAL FILLERS)
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Merz North America, Inc.
- Date received
- 2017-01-18
- Decision date
- 2017-04-26
- Days to decision
- 98 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Franksville, WI
- Statement
- Approval for changes to the protocol for the post-approval study (PAS) protocol.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| DESCRIBE PFD Patch (K172689) | Merz North America, Inc. | 2017-11-29 |